Tom Klima

Tom, who joined the flock in May of 2021 as the Chief Commercial Officer, has deep passion for patients and experience across multiple commercial roles in both rare diseases and oncology. Most recently, Tom served as Chief Commercial Officer at Gamida Cell, leading a high-growth, fast paced oncology cell therapy organization and establishing a culture of transparency, trust and empowerment. Prior to his tenure at Gamida Cell, Tom served in a variety of leadership roles at Atara Biotherapeutics, Navidea Biopharmaceuticals and Algeta U.S. where he led the successful commercial build-out and launch of Xofigo®. Before Algeta, he held various commercial leadership positions at Dendreon. Tom began his pharmaceutical career at Eli Lilly where he held several positions of increasing responsibility and participated in the global launch of Cymbalta®. Tom earned a B.A. in Business Administration and Marketing from Western State College.